ArticleFrontiers in medicine2026

Low-dose daratumumab and bortezomib for the treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a case report.

Jiaomei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.